Literature DB >> 19502387

TLR-4-mediated innate immunity is reduced in cystic fibrosis airway cells.

Gerrit John1, Ali O Yildirim, Bruce K Rubin, Dieter C Gruenert, Markus O Henke.   

Abstract

Airway epithelial cells contribute to the inflammatory response of the lung, and their innate immune response is primarily mediated via Toll-like receptor (TLR) signaling. Cystic fibrosis (CF) airways are chronically infected with Pseudomonas aeruginosa, suggesting a modified immune response in CF. We investigated the TLR-4 expression and the inflammatory profile (IL-8 and IL-6 secretion) in CF bronchial epithelial cell line CFBE41o- and its CF transmembrane ion condcutance regulator (CFTR)-corrected counterpart grown under air-liquid interface conditions after stimulation with lipopolysaccharide (LPS) from gram-negative bacteria. In CFTR-corrected cells, IL-8 and IL-6 secretions were constitutively activated but significantly increased after LPS stimulation compared with CFBE41o-. Blocking TLR-4 by a specific antibody significantly inhibited IL-8 secretion only in CFTR-corrected cells. Transfection with specific siRNA directed against TLR-4 mRNA significantly reduced the response to LPS in both cell lines. Fluorescence-activated cell sorter analysis revealed significantly higher levels of TLR-4 surface expression in CFTR-corrected cells. In histologic lung sections of patients with CF, the TLR-4 expression in the bronchial epithelium was significantly reduced compared with healthy control subjects. In CF the loss of CFTR function appears to decrease innate immune responses, possibly by altering the expression of TLR-4 on airway epithelial cells. This may contribute to chronic bacterial infection of CF airways.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19502387      PMCID: PMC5459530          DOI: 10.1165/rcmb.2008-0408OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  71 in total

Review 1.  Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis.

Authors:  M J Welsh; A E Smith
Journal:  Cell       Date:  1993-07-02       Impact factor: 41.582

2.  Proinflammatory cytokine responses to P. aeruginosa infection in human airway epithelial cell lines.

Authors:  D Kube; U Sontich; D Fletcher; P B Davis
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-03       Impact factor: 5.464

3.  Dysregulated cytokine production in human cystic fibrosis bronchial epithelial cells.

Authors:  A A Stecenko; G King; K Torii; R M Breyer; R Dworski; T S Blackwell; J W Christman; K L Brigham
Journal:  Inflammation       Date:  2001-06       Impact factor: 4.092

4.  Studies on pulmonary secretions. 3. The nucleic acids in whole pulmonary secretions from patients with cystic fibrosis, bronchiectasis, and laryngectomy.

Authors:  J L Potter; S Spector; L W Matthews; J Lemm
Journal:  Am Rev Respir Dis       Date:  1969-06

5.  Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis.

Authors:  D S Armstrong; K Grimwood; R Carzino; J B Carlin; A Olinsky; P D Phelan
Journal:  BMJ       Date:  1995-06-17

6.  Increased sulfation of glycoconjugates by cultured nasal epithelial cells from patients with cystic fibrosis.

Authors:  P W Cheng; T F Boat; K Cranfill; J R Yankaskas; R C Boucher
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

7.  Release of interleukin-8, interleukin-6, and colony-stimulating factors by upper airway epithelial cells: implications for cystic fibrosis.

Authors:  M Bédard; C D McClure; N L Schiller; C Francoeur; A Cantin; M Denis
Journal:  Am J Respir Cell Mol Biol       Date:  1993-10       Impact factor: 6.914

8.  Inflammatory cytokines in cystic fibrosis lungs.

Authors:  T L Bonfield; J R Panuska; M W Konstan; K A Hilliard; J B Hilliard; H Ghnaim; M Berger
Journal:  Am J Respir Crit Care Med       Date:  1995-12       Impact factor: 21.405

9.  Identification of the cystic fibrosis gene: chromosome walking and jumping.

Authors:  J M Rommens; M C Iannuzzi; B Kerem; M L Drumm; G Melmer; M Dean; R Rozmahel; J L Cole; D Kennedy; N Hidaka
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

10.  MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions.

Authors:  Markus O Henke; Armin Renner; Rudolf M Huber; Michael C Seeds; Bruce K Rubin
Journal:  Am J Respir Cell Mol Biol       Date:  2004-02-26       Impact factor: 6.914

View more
  35 in total

Review 1.  Fungal Pathogens in CF Airways: Leave or Treat?

Authors:  A Singh; A Ralhan; C Schwarz; D Hartl; A Hector
Journal:  Mycopathologia       Date:  2017-08-02       Impact factor: 2.574

2.  Postnatal episodic ozone results in persistent attenuation of pulmonary and peripheral blood responses to LPS challenge.

Authors:  Kinjal Maniar-Hew; Edward M Postlethwait; Michelle V Fanucchi; Carol A Ballinger; Michael J Evans; Jack R Harkema; Stephan A Carey; Ruth J McDonald; Alfred A Bartolucci; Lisa A Miller
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-12-03       Impact factor: 5.464

3.  Inhibition of high-mobility group box 1 protein (HMGB1) enhances bacterial clearance and protects against Pseudomonas Aeruginosa pneumonia in cystic fibrosis.

Authors:  Maria Entezari; Daniel J Weiss; Ravikumar Sitapara; Laurie Whittaker; Matthew J Wargo; JianHua Li; Haichao Wang; Huan Yang; Lokesh Sharma; Binh D Phan; Mohammad Javdan; Sangeeta S Chavan; Edmund J Miller; Kevin J Tracey; Lin L Mantell
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

Review 4.  Toll like receptors in diseases of the lung.

Authors:  Melissa A Kovach; Theodore J Standiford
Journal:  Int Immunopharmacol       Date:  2011-05-30       Impact factor: 4.932

Review 5.  Innate immunity in the respiratory epithelium.

Authors:  Dane Parker; Alice Prince
Journal:  Am J Respir Cell Mol Biol       Date:  2011-02-17       Impact factor: 6.914

Review 6.  Protein processing and inflammatory signaling in Cystic Fibrosis: challenges and therapeutic strategies.

Authors:  C N Belcher; N Vij
Journal:  Curr Mol Med       Date:  2010-02       Impact factor: 2.222

7.  Airway epithelial expression of TLR5 is downregulated in healthy smokers and smokers with chronic obstructive pulmonary disease.

Authors:  Rui Wang; Joumana Ahmed; Guoqing Wang; Ibrahim Hassan; Yael Strulovici-Barel; Jacqueline Salit; Jason G Mezey; Ronald G Crystal
Journal:  J Immunol       Date:  2012-08-01       Impact factor: 5.422

8.  Innate immune response to LPS in airway epithelium is dependent on chronological age and antecedent exposures.

Authors:  Kinjal Maniar-Hew; Candice C Clay; Edward M Postlethwait; Michael J Evans; Justin H Fontaine; Lisa A Miller
Journal:  Am J Respir Cell Mol Biol       Date:  2013-11       Impact factor: 6.914

Review 9.  Chemoattractants and cytokines in primary ciliary dyskinesia and cystic fibrosis: key players in chronic respiratory diseases.

Authors:  Maaike Cockx; Mieke Gouwy; Jo Van Damme; Sofie Struyf
Journal:  Cell Mol Immunol       Date:  2017-11-27       Impact factor: 11.530

10.  The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity.

Authors:  Romina Fiorotto; Ambra Villani; Antonis Kourtidis; Roberto Scirpo; Mariangela Amenduni; Peter J Geibel; Massimiliano Cadamuro; Carlo Spirli; Panos Z Anastasiadis; Mario Strazzabosco
Journal:  Hepatology       Date:  2016-10-27       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.